Browsing ICR Divisions by author "De Boisanger, James"
Now showing items 1-1 of 1
-
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Vasiliadou, I; Grose, D; Wilson, C; Thapa, A; Donnelly, O; et al. (WILEY, 2024-09-01)Pembrolizumab has received approval in the UK as first-line monotherapy for recurrent and/or metastatic HNSCC (R/M HNSCC) following the results of the KEYNOTE-048 trial, which demonstrated a longer overall survival (OS) ...